Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Changes

29 Jan 2025 07:00

RNS Number : 9976U
Chesnara PLC
29 January 2025
 

 

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

29th January 2025

 

CHESNARA plc

("Chesnara", "the Company" or the "Group")

 

BOARD CHANGES

 

Chesnara (CSN.L), the European life insurance consolidator, today announces the appointment of Gail Tucker as Non-Executive Director with immediate effect. Gail has also been appointed as a member of Audit & Risk Committee and Nomination & Governance Committee and will be proposed for election at the Company's AGM, expected to be on 13th May 2025. Gail also joins the Board of Chesnara's UK subsidiary, Countrywide Assured plc as a Non-Executive Director and it is intended will chair its Audit & Risk Committee subject to regulatory approval.

 

Jane Dale, Non-Executive Director, will stand down at the AGM having completed her 9-year term. At the same time, Gail Tucker will be appointed chair of the Audit & Risk Committee.

 

Gail is a recently retired 'Big Four' partner with over 30 years' experience in financial services audit, predominantly focused on the insurance sector. She has a high level of technical competence in international accounting and financial reporting, allied to which she brings a well-developed perspective on the UK life and pensions industry. A qualified accountant, Gail holds a BSc from the University of Warwick and a BA from The Open University. She sits on the boards of Breast Cancer Now and Institute of Chartered Accountants in England & Wales (ICAEW) Financial Services Board.

 

Chair Luke Savage commented:

 

'I am delighted to welcome Gail to the Board of Chesnara and she brings with her a wealth of reporting expertise including from her time as IFRS17 Global Technical Lead for PwC. She has advised insurance audit teams around the world and has sat on a number of technical committees. We are delighted to have attracted such talent into the group and I look forward to working with Gail as we prosecute our strategy and deliver further value to our policyholders and shareholders.'

 

There is no further information relating to Gail which would require disclosure under UKLR 6.4.8R.

 

 

 

For further information, please contact:

 

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

 

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493 

E - roddy.watt@fwdconsulting.co.uk

 

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 20 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVORVOUAUAR
Date   Source Headline
17th May 20137:00 amRNSInterim Management Statement
25th Apr 20139:06 amRNSHolding(s) in Company
19th Apr 20139:23 amRNSHolding(s) in Company
19th Apr 20138:55 amRNSHolding(s) in Company
18th Apr 201311:47 amRNSAnnual Financial Report
11th Apr 20137:00 amRNSAnnual Report and Accounts and Notice of AGM
28th Mar 20133:28 pmRNSTotal Voting Rights
28th Mar 20137:00 amRNSFinal Results
8th Mar 20138:13 amRNSNotice of Results
1st Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
1st Feb 20131:39 pmRNSHolding(s) in Company
16th Jan 20137:00 amRNSDirectorate Change
6th Dec 20121:33 pmRNSHolding(s) in Company
21st Nov 20122:00 pmRNSDirectorate Change
16th Nov 20127:00 amRNSInterim Management Statement
24th Oct 201210:51 amRNSHolding(s) in Company
5th Sep 201212:15 pmRNSHolding(s) in Company
31st Aug 20127:00 amRNSHalf Yearly Report
10th Aug 20123:59 pmRNSNotice of Results
12th Jun 20129:40 amRNSDirector/PDMR Shareholding
1st Jun 201211:47 amRNSDirector/PDMR Shareholding
18th May 201211:53 amRNSResult of AGM
18th May 20127:00 amRNSInterim Management Statement
24th Apr 20129:23 amRNSAnnual Financial Report
11th Apr 20127:00 amRNSStatement re Posting of Annual Report and Accounts
30th Mar 20129:00 amRNSAnnual Information Update
30th Mar 20127:00 amRNSFinal Results
5th Mar 20121:41 pmRNSNotice of Results
28th Feb 201212:07 pmRNSHolding(s) in Company
14th Feb 20122:10 pmRNSDirector/PDMR Shareholding
9th Feb 20129:53 amRNSHolding(s) in Company
8th Feb 20128:53 amRNSHolding(s) in Company
1st Feb 201211:43 amRNSHolding(s) in Company
16th Jan 20124:21 pmRNSHolding(s) in Company
15th Dec 201112:11 pmRNSSave & Prosper Part VII Transfer Approved
12th Dec 20113:18 pmRNSHolding(s) in Company
18th Nov 20117:00 amRNSInterim Management Statement
20th Oct 20115:45 pmPRNAnnouncement Released in Error
14th Oct 201110:06 amRNSHolding(s) in Company
6th Oct 20114:35 pmRNSPrice Monitoring Extension
31st Aug 20117:00 amPRNHalf-yearly Report
1st Aug 20113:23 pmPRNNotice of Interim Results
19th May 20117:00 amPRN1st Quarter Results
19th May 20117:00 amPRN1st Quarter Results
17th May 201111:57 amPRNResult of AGM
13th Apr 20114:42 pmPRNAnnual Financial Report
1st Apr 20119:20 amPRNAnnual Information Update
31st Mar 20117:00 amPRNFinal Results
4th Mar 20113:21 pmPRNNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.